We report marked differences in the use of confirmatory kidney function testing (eGFR, creatinine/cystatin C, mGFR, creatinine clearance), albuminuria assessment, and the acceptance policy of donors with nephrolithiasis. This evidence concerns the gene CST3 and nephrolithiasis.